Stem Cells Heal Crohn’s Fistula in Clinical Trial

Stem Cells Heal Crohn’s Fistula in Clinical Trial
shutterstock_223048555Patients with Crohn's fistula may benefit from therapy with autologous adipose-derived stem cells (ASCs), according to the results of a phase 2 clinical trial conducted by five medical institutions in collaboration with Anterogen Co., Ltd., in Korea. No adverse effects and a benefit in nearly all patients a year after treatment indicates treatment was a success. "It strongly demonstrated [mesenchymal stem cells (MSCs)] derived from ASCs are a safe and useful therapeutic tool for the treatment of Crohn's fistula," said principal investigator Dr. Chang Sik Yu, in a news release from the publishing journal. The article, "Long-Term Results of Adipose-Derived Stem Cell Therapy for the Treatment of Crohn's Fistula," was published in Stem Cells Translational Medicine. The current study was a follow-up to the phase 2 clinical trial that injected self-donor fat-derived ASCs into 43 patients who had Crohn's fistula, or abnormal connections between the intestines and other organs or skin that can eventually lead to life-threatening infections and abscesses. These fistulas a
Subscribe or to access all post and page content.

One comment

  1. Tonia Moore says:

    I want to know is there anyone that is doing stem cell studies for crohn’s fistulas in southern california?? I suffer from it.

Leave a Comment

Your email address will not be published. Required fields are marked *